Editorial Board Members from Epigenomes Featured in Stanford’s List of the World’s Top 2% Scientists

Stanford University has recently published an update of the list of the top 2% most widely cited scientists—the World’s Top 2% Scientists.

The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.

We are pleased to share that 38 Editorial Board Members from MDPI’s journal Epigenomes (ISSN: 2075-4655) were featured in Stanford University World’s Top 2% Scientists list in 2022.

Name	Affiliation
Prof. Dr. Albert Jeltsch	Universität Stuttgart
Prof. Dr. Andrew E. Teschendorff	University of Chinese Academy of Sciences
Prof. Dr. Assam El-Osta	Monash University
Prof. Dr. Bin Tean Teh	National Cancer Centre, Singapore
Prof. Dr. Craig L. Peterson	University of Massachusetts Chan Medical School
Dr. Daniel De Carvalho	Ontario Cancer Institute University of Toronto
Dr. Eric Lieberman Greer	Harvard Medical School
Prof. Dr. Ernesto Guccione	Icahn School of Medicine at Mount Sinai
Prof. Dr. Frank Lyko	DKFZ‑ZMBH Alliance
Dr. Giacomo Cavalli	Institute of Human Genetics, University of Montpellier
Prof. Dr. Hendrik G. Stunnenberg	Radboud Institute for Molecular Life Sciences
Prof. Dr. Isabelle Mansuy	Universität Zürich
Dr. James M. Flanagan	Imperial College London
Prof. Dr. Jörn Walter	Universität des Saarlandes
Prof. Dr. Juan Ausió	University of Victoria
Dr. László Tora	Inserm
Prof. Dr. Luciano Di Croce	Centre for Genomic Regulation (CRG)
Prof. Dr. Marco Giorgio	University of Padua
Dr. Martin E. Fernandez-Zapico	Mayo Clinic
Prof. Dr. Melanie Ehrlich	Tulane University School of Medicine
Prof. Dr. Olga Kovalchuk	University of Lethbridge
Dr. Patrick O. McGowan	University of Toronto
Prof. Dr. Paul A. Wade	National Institute of Environmental Health Sciences
Prof. Dr. Peter C. Dedon	Massachusetts Institute of Technology
Prof. Dr. Qian Tao	Prince of Wales Hospital Hong Kong
Prof. Dr. Richard L. Momparler	CHU Sainte-Justine - Le Centre Hospitalier Universitaire Mère-Enfant
Prof. Dr. Robert A. Waterland	Baylor College of Medicine
Dr. Robert Feil	Centre National de Recherche Scientifique (CNRS)
Dr. Robert J. Schmitz	University of Georgia
Dr. Roderic Guigó	Centre for Genomic Regulation (CRG)
Dr. Ryan Lister	The University of Western Australia
Prof. Dr. Ryszard Maleszka	Australian National University
Prof. Dr. Steven E. Jacobsen	University of California, Los Angeles
Prof. Dr. Susan J. Clark	Garvan Institute of Medical Research
Prof. Dr. Ueli Grossniklaus	University of Zürich
Prof. Dr. Victor G. Corces	Emory University School of Medicine
Prof. Dr. Xiaodong Cheng	The University of Texas MD Anderson Cancer Center
Prof. Dr. Yasushi Hiraoka	Osaka University

The latest Stanford rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world.

We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Epigenomes.